The landscape of medical weight management has shifted dramatically. With several high-profile medications now available in Singapore, the most common question we hear at MyDoctor is: “Which one actually works best?”
While all three medications—Ozempic, Mounjaro, and Rybelsus—belong to a class of drugs that mimic hormones to regulate appetite, they are not identical. Choosing the right one depends on your metabolic profile, lifestyle, and comfort level with treatment.
The Injectables: Ozempic vs. Mounjaro
Both are once-weekly injections, but their chemical makeup differs:
- Ozempic (Semaglutide): A GLP-1 receptor agonist. It mimics the hormone that tells your brain you are full and slows down stomach emptying. It has a long-standing safety profile and is highly effective for sustainable weight loss.
- Mounjaro (Tirzepatide): Often called a “dual-agonist.” It mimics two hormones: GLP-1 and GIP. Clinical data suggests that by targeting two pathways, Mounjaro may lead to a slightly higher percentage of total body weight loss compared to Semaglutide.
The Oral Alternative: Rybelsus
For those who are needle-averse, Rybelsus is a game-changer. It contains the same active ingredient as Ozempic (Semaglutide) but in a daily pill form. While the efficacy is comparable, it requires strict adherence to a morning routine to ensure the medication is absorbed correctly.
Which is right for you?
- Choose Mounjaro if: You have a significant amount of weight to lose and want the highest clinical potency currently available.
- Choose Ozempic if: You prefer a weekly routine with a well-established track record and balanced efficacy.
- Choose Rybelsus if: You travel frequently or simply prefer the convenience of a daily tablet over an injection.
At MyDoctor, we don’t believe in a one-size-fits-all approach. A consultation involves reviewing your blood work and lifestyle to ensure your choice is both safe and effective.